This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
April 28–29, 2026
Kerry Hotel Pudong, Shanghai, ChinaMay 6–7, 2026 - Digital Partnering
Book Now
Menu
Book Now

Ming Wu
Vice President at TYK Medicines Inc
Presenter

Profile

TYK Medicines is a fast growing international biotech focused on innovative anti-cancer drugs, which launched IPO in Hong Kong in 2024 (stock code: 2410.HK).

Agenda Sessions

  • Oncology: TYK Medicines Inc

    , 12:00
    View Session

At this event

Prev
Next
Tom Wu
Head of Development Strategy, Ops & AbbVie Ventures, China
AbbVie

See Ming at ChinaBio® Partnering Forum

Book Now